Jun 12, 2020
FDA Approves Drug to Treat Infants and Children with HIV
May 22, 2020
Global Antiretroviral Therapy Market (NRTI, NNRTI, Protease Inhibitors & Integrase Inhibitors): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
May 04, 2020
Viriom Announces Initiation of Phase 2 Study Investigating Efficacy of Intramuscular Long-Acting Injectable Nanoformulation of VM1500A in HIV-Infected Patients
Nov 05, 2019
FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Oct 03, 2019
GT Biopharma Announces HIV TriKE(TM) Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
Sep 26, 2019
GT Biopharma Announces HIV Trike(TM) Data to be Published
Sep 03, 2019
Viriom announces NIH/NIAID and Division of AIDS Collaboration with the Long-Acting/Extended Release Antiviral Resource Program
Jul 02, 2019
Viriom Signed Licensing Agreement for Indonesia with P.T. Lloyd Pharma
Jun 03, 2019
Viriom Files for Market Authorization in China
Apr 29, 2019
Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV
Apr 17, 2019
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
Dec 21, 2018
Viriom to Report Results from Phase 1b Clinical Trial of Once Weekly Oral HIV Treatment
Dec 20, 2018
Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment
Dec 17, 2018
Mylan Adds First Generic for Canasa® Rectal Suppository to Growing Gastroenterology Portfolio
Nov 19, 2018
IBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agents
Nov 15, 2018
Global HIV Diagnostics and Therapeutics Markets Report 2018-2023 Featuring Abbott Laboratories, Bio-Rad Laboratories, Cipla, GSK, Merck & Co., Siemens Healthineers and Thermo Fisher Scientific
Oct 31, 2018
Zion Medical Announces Results of First Human Clinical Trial of HIV drug Gammora, Offering Potential Cure
Aug 15, 2018
Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1
May 02, 2018
The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network
Mar 28, 2018
Mylan Introduces Symfi(TM) Triple Combo Once-Daily HIV Treatment in the U.S.